Moderna Inc. Stock Advances 4.1%, Outperforms Peers
Dow Jones2026/10/19 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. rallied 4.1% to $226.88 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 26,430.89 and the Dow Jones Industrial Average falling 0.1% to 51,966.03.
Moderna Inc. closed 6.4% short of its 52-week high of $242.29, which the company achieved on October 15th.
The stock outperformed some of its peers, as Johnson & Johnson fell 0.7% to $253.79, Pfizer Inc. fell 0.5% to $29.44, and Gilead Sciences Inc. fell 1.97% to $153.11.
Trading volume totaled 18.7 million, compared to the 50-day average of 23.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 19, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Saudi "Desert Davos" postponed to 2027: $50 billion signing window closes, narrative of "global business hub" suffers setback
The "Future Investment Initiative" summit in Saudi Arabia, known as the "Desert Davos," has announced its postponement. The 10th edition of the event, originally scheduled to take place in Riyadh from October 26 to 29, has been postponed until 2027. The delay is due to ongoing attacks by Houthi forces targeting locations within Saudi Arabia, including Riyadh Airport and the Saudi Aramco headquarters. According to the draft agenda, planned attendees included senior executives from financial giants such as Goldman Sachs, JPMorgan, and Blackstone.
BUZZ-Steel Dynamics stock falls as quarterly profit misses expectations
Coca-Cola Announces Dividend of R$ 0.29564105286 per Unit
Crypto prices
More
